Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-071707
Filing Date
2025-05-14
Accepted
2025-05-14 18:21:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7482
  Complete submission text file 0000950170-25-071707.txt   8959
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address
Sommadossi Jean-Pierre (Filed by) CIK: 0001296995 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Subject) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91836 | Film No.: 25947589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)